A Comparison of the Efficacy of Trastuzumab Deruxtecan in Advanced HER2-positive Breast Cancer: Active Brain Metastasis Versus Progressive Extracranial Disease Alone.
ESMO OPEN（2023）
Key words
breast cancer,HER2,trastuzumab deruxtecan,brain metastases
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined